Patent · US Active

Products and compositions

US11015198B2 · kind B2 · utility

8Cited by

5References

7Claims

0Family size

Assignee

Sapience Therapeutics, Inc. · DE

Inventors

Judith Hauptmann · Berlin, DE
Dmitry Samarsky · Berlin, DE
Christian Frauendorf · Berlin, DE

Key dates

Filing date	Apr 5, 2018
Grant date	May 25, 2021
Priority date	—
Expiry date	Apr 5, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/351
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with gene expression or inhibits its expression and therapeutic uses such as for the treatment of disease and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.